- For Dose Confirmation Phase SCLC Arm: Have histologically- or cytologically-confirmed advanced/metastatic SCLC. Participants must have received one prior treatment regimen with a platinum-containing agent. Participants with platinum refractory, resistant, or sensitive disease are eligible. Participants with an initial diagnosis of limited or extensive disease are eligible but must now have advanced (Stage III/IV) disease